Cheng Minghe, who currently serves as the company's chief strategic officer -- a position he will maintain -- will join company President Li Xiting in leading the device maker.
Cheng is a co-founder of the company and as such has served in various roles since it was established in 1991, including in sales, marketing, and strategic development. As co-CEO, he will assist Li in executing Mindray's strategies and overseeing its operations.
"I am very excited about Mr. Cheng's appointment as the co-CEO," Li was quoted as saying. "His extensive experience and exceptional leadership skills made him an ideal candidate for this role. I look forward to him joining me in fulfilling our company's vision and mission in the future."
The medical device maker also announced several other executive changes, including the appointment of Wang Jianxin as chief administrative officer and May Li as chief investment officer. Wang previously served as vice president of Mindray while May Li was previously the deputy CFO. All of the appointments will take effect immediately.
Headquartered in Shenzhen, China, Mindray Medical had nearly $1.1 billion in revenues over the trailing-12-month period ending March 31.